Xing Feng
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
SLC2A1-Dependent Ketone Metabolism Regulates Tumor Progression and Immunotherapy Efficacy in Lung Adenocarcinoma.
Journal: Critical reviews in immunology
Published: June 01, 2026
Development of a machine learning-based model to predict prognosis of resected invasive pulmonary adenocarcinoma.
Journal: Journal of thoracic disease
Published: August 14, 2025
Periostin Induces Epithelial-Mesenchymal Transition via p38-MAPK Pathway in Human Renal Tubular Cells by High Glucose.
Journal: Immunity, inflammation and disease
Published: March 03, 2024
Long-term survival of stage Ib lung adenocarcinoma with postoperative brain oligometastasis: a case report and literature review.
Journal: Folia neuropathologica
Published: January 04, 2024
Corrigendum: Docetaxel-loaded novel nano-platform for synergistic therapy of non-small cell lung cancer.
Journal: Frontiers in pharmacology
Published: June 08, 2022
Docetaxel-Loaded Novel Nano-Platform for Synergistic Therapy of Non-Small Cell Lung Cancer.
Journal: Frontiers in pharmacology
Published: December 10, 2021
CircRIP2 promotes NSCLC progression by sponging for miR-671-5p to regulate FOXM1 expression.
Journal: Histology and histopathology
Published: July 22, 2021
GTSE1 Facilitates the Malignant Phenotype of Lung Cancer Cells via Activating AKT/mTOR Signaling.
Journal: Analytical cellular pathology (Amsterdam)
Published: February 01, 2021
FKBP4 Accelerates Malignant Progression of Non-Small-Cell Lung Cancer by Activating the Akt/mTOR Signaling Pathway.
Journal: Analytical cellular pathology (Amsterdam)
Published: July 31, 2020
GPRC5a suppresses the proliferation of non-small cell lung cancer under wild type p53 background.
Journal: Experimental lung research
Published: May 16, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026